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ABSTRACT: Introduction: Phosphoglycerate mutase defi-
ciency (PGAM) is a rare metabolic myopathy that results in ter-
minal block in glycogenolysis. Clinically, patients with PGAM
deficiency are asymptomatic, except when they engage in brief,
strenuous efforts, which may trigger myalgias, cramps, muscle
necrosis, and myoglobinuria. An unusual pathologic feature of
PGAM deficiency is the association with tubular aggregates.
Methods: We report an African-American patient from Pan-
ama with partial deficiency of PGAM who presented with
asymptomatic elevation of creatine kinase levels and tubular
aggregates on muscle biopsy. Results: Muscle biopsies
showed subsarcolemmal and sarcolemmal tubular aggregates
in type 2 fibers. Muscle PGAM enzymatic activity was
decreased and gene sequencing revealed a heterozygous
mutation in codon 78 of exon 1 of the PGAM2 gene, which is
located on the short arm of chromosome 7. Conclusions: P-
GAM deficiency has been reported in 14 patients, 9 of whom
were of African-American ethnicity, and in 5 (36%) tubular
aggregates were seen on muscle biopsy. Contrary to previously
reported cases, our patient was initially asymptomatic. This fur-
ther expands the PGAM deficiency phenotype.
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Phosphoglycerate mutase (PGAM) deficiency (gly-
cogen-storage disease type X) is a muscle glycogen-
storage disease that results in a terminal block in
glycogenolysis. It usually presents with exercise-
induced cramps and recurrent myoglobinuria.
Recently, Tonin et al. described 14 patients with
PGAM deficiency, 9 of whom were African-Ameri-
can (64%). In 5 of the 14 patients (36%), tubular
aggregates (TAs) were seen on muscle biopsy.1–9
Here we report a patient from Panama with
partial deficiency of PGAM who presented with
asymptomatic elevation of creatine kinase (CK) lev-
els on multiple occasions and TAs in muscle bi-
opsy. PGAM deficiency is a rare autosomal-reces-
sive disorder that is more commonly seen in
African-Americans. The most common gene defect
reported is a nonsense mutation at codon 78, but
different mutations have been described in Italian,
Japanese, and Pakistani patients.
CASE REPORT
A 43-year-old, right-handed black man, who lived
in Panama since his parents moved there when he
was a child (his father was from Jamaica and
mother from Barbados, and there was no consan-
guinity), was referred to our neuromuscular unit
for evaluation of elevated serum CK levels. In
1992, he was evaluated by an ophthalmologist at
an outside hospital 9 years prior to our initial eval-
uation for a right eye lower visual field defect. His
work-up at that time revealed elevated serum CK.
Six years prior to presentation, he was evaluated
for incidentally elevated CK by another neurolo-
gist, who performed nerve conduction studies
(NCS) and electromyography (EMG) and found
both studies to be normal. A quadriceps muscle bi-
opsy was performed in 1995, which revealed sub-
sarcolemmal aggregates.
Upon presentation to our neuromuscular unit,
the patient denied weakness, myalgia, myoglobinu-
ria, muscle cramps, or exercise intolerance. He
mentioned mild fatigue and subtle weakness of his
left upper extremity only after strenuous exercise.
Over 2 decades after his initial evaluation for
asymptomatic hyperCKemia, he reported muscle
cramps with running or heavy (>30 pounds)
weight-lifting. His past medical history is significant
for a history of hepatitis A. There was no family
history of neuromuscular diseases and no known
consanguinity in the family. He has a son and a
daughter who are both healthy and have no similar
complaints.
General physical examination was unremark-
able. His cranial nerve examination revealed a
right inferior quadrant visual field deficit. Manual
muscle strength testing was normal. The biceps
reflex was 1þ on the right and absent on the left.
Otherwise, triceps, brachioradialis, knee, and ankle
reflexes were symmetric and normal. His sensory
examination was also normal.
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His blood work-up showed elevated serum CKs
ranging from 362 to 16,445 U/L (normal: 60–348
U/L). He also had elevated levels of aldolase at
21.5 U/L (2.0–7.0 U/L), serum glutamic oxaloace-
tic transaminase (SGOT) 239 U/L (10–40 U/L),
and serum glutamic pyruvic transaminase (SGPT)
124 U/L (10–55 U/L). The remaining laboratory
tests were all normal, including urinalysis, com-
plete blood count, blood urea nitrogen, hepatitis B
and C, bilirubin, rheumatoid factor, antinuclear
antibodies, thyroid-stimulating hormone, serum
myoglobin, angiotensin-converting enzyme, and
erythrocyte sedimentation rate. DNA testing for
Becker muscular dystrophy and Leber hereditary
optic neuropathy were also negative. NCS/EMG
testing was performed and showed normal bilateral
median, ulnar, and medial and lateral antebrachial
cutaneous sensory nerve action potentials. Bilateral
median and ulnar compound muscle action poten-
tials with F-wave responses were all normal. Needle
EMG of both the left arm and cervical paraspinal
muscles was normal. A forearm exercise test was
performed and revealed a normal rise in lactate
and ammonia. Chest radiograph, brain, and cervi-
cal spine magnetic resonance imaging (MRI) were
unremarkable.
A right quadriceps muscle biopsy was per-
formed at a time when the patient was asymptom-
atic. Light microscopy revealed increased variation
in fiber size with several angulated atrophic fibers
on hematoxylin and eosin (H&E) staining. There
was no evidence of inflammation, fibrosis, or
increased numbers of internal nuclei. Many fibers
contained irregular basophilic aggregates in the
center of the fiber and in the subsarcolemmal
space. These aggregates were red on Gomori tri-
chrome stain. They were strongly positive for nico-
tinamide adenine dehydrogenase (NADH) stain.
Adenosine triphosphatase (ATPase) staining (at
pH 4.3, 4.6, and 9.4) showed that the aggregates
did not stain and were present almost exclusively
in type 2 fibers. In addition, there was evidence of
glycogen accumulation in some fibers with peri-
odic acid–Schiff (PAS) staining. There was no evi-
dence of fiber type grouping. Electron microscopy
(EM) demonstrated subsarcolemmal and central
cytoplasmic aggregates within myofibers. By ultra-
structural analysis these aggregates were composed
of double-walled tubules with a diameter of
approximately 50 nm. The tubules contained
smaller inner granular cores of approximately 20-
nm diameter. There were distinct boundaries
between the TAs and adjacent sarcomeres (Fig. 1).
Glycogen deposits were also present, but they were
seen in relation to the TAs mentioned previously.
The mitochondria, nuclei, and contractile appara-
tus were unremarkable.
Biochemical analysis for myoglobinuria was per-
formed spectrophotometrically and by radionuclide
incorporation (Athena Diagnostics, Worcester, Mas-
sachusetts). A partial deficiency of phosphoglycer-
ate mutase was noted at 40.5 lmol/min/g of tissue
(normal: >181.75 lmol/min/g). All other enzymes
analyzed were normal, including total phosphoryl-
ase A, phosphorylase b kinase, myoadenylate deami-
nase, phosphoglycerate kinase, lactate dehydrogen-
ase, carnitine palmitoyltransferase, glycogen, and
phosphofructokinase (with phosphofructokinase as
the control enzyme). Sequencing of three exons of
FIGURE 1. Pathologic features of tubular aggregates and gly-
cogen deposition. (a) Hematoxylin and eosin staining shows
irregular basophilic aggregates in the center of the fiber and
subsarcolemmal spaces. (b) The aggregates are red by Gomori
trichome staining. (c) PAS highlights areas with glycogen depo-
sition in the center of the fibers. (d) NADH highlights in dark
blue some of the subsarcolemmal aggregates. (e) ATPase at
pH 4.6 shows that the aggregates are limited to the type 2
fibers (pale brown fibers) and are not present in type 1 fibers
(the 2 dark brown fibers). (f–h) Electron microscopy. (f) Glyco-
gen deposits at the center of the fiber, showing no association
with tubular aggregates. (g) Subsarcolemmal tubular aggre-
gates running in parallel and cross-section. (h) Higher magnifi-
cation of tubular aggregates in cross-sections showing double-
walled tubules arranged in a honeycomb architecture. Each
tubule has a diameter of approximately 50 nm, and inside there
are fine granular cores of approximately 20 nm. Magnification
bars: (a–e) 100 lm; (f, g) 2 lm; and (h) 500 nm.
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the PGAM2 gene on chromosome 7P13 revealed a
heterozygous mutation in codon 78 of exon 1
(c233G>A, P. W78X). This mutation has been
reported previously in homozygous patients with
PGAM deficiency.
DISCUSSION
Phosphoglycerate mutase deficiency (GSDX) is a
rare muscle glycogenosis that results in a terminal
block in glycogenolysis. Since 1981, when PGAM
deficiency was first described, 14 patients have
been reported (Table 1). Clinically, these patients
are typically asymptomatic except when they
engage in brief, strenuous efforts, which may trig-
ger myalgias, cramps, muscle necrosis, and myoglo-
binuria. An unusual pathologic feature of PGAM
deficiency is the association with tubular aggre-
gates, which has been reported in about 36% of
patients.1–9
Tubular aggregates are densely packed mem-
branous tubules derived from the sarcoplasmic
reticulum. They represent nonspecific pathologic
changes seen in diverse conditions such as expo-
sure to drugs, toxins, and hypoxia, in addition to
muscle PGAM deficiency. Clinical features that
have been reported previously with TAs on muscle
biopsy include periodic paralysis, leg weakness,
myotonia, muscle cramps, proximal weakness, neu-
ropathy, ‘‘tremor,’’ exercise-induced cramps, and
myoglobinuria.2 An unusual feature in our patient
was the lack of symptoms on initial presentation
and for many years thereafter. Over 2 decades
later, the patient developed muscle cramps with
running or heavy (>30 pounds) weight-lifting. He
never had myoglobinuria, although this condition
has been reported in the triad associated with
PGAM deficiency (exercise-induced cramps, recur-
rent myoglobinuria, and TAs on muscle biopsy).2
For many years, he was followed for ‘‘idiopathic
hyperCKemia,’’ which in retrospect raises the ques-
tion of what percent of patients with this diagnosis
are actually unrecognized heterozygous mutations
of genes associated with recognizable hereditary
muscle diseases when they are homozygous, as in
this case.
Despite the large amount of new information,
the specific trigger and the definitive insult in
PGAM deficiency remains unknown. The geno-
type–phenotype correlation is still weak, and no
therapy is presently available. Contrary to previ-
ously reported cases, our patient was initially
asymptomatic, which further expands the PGAM
deficiency phenotype.
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Table 1. Clinical, ethnicity, muscle biopsy, and genetic characteristics of patients with PGAM deficiency.
Pt. Gender/age (y) Ethnicity Clinical features Muscle biopsy findings Gene defect
1 M/52 AA Cramps, myoglobinuria NT
2 F/17 AA Cramps, myoglobinuria W78X
3 M/24 AA Cramps, myoglobinuria Tubular aggregates W78X
4 M/17 AA Cramps W78X
5 M/30 AA Cramps, myoglobinuria W78X/E89A
6 F/34 AA Cramps, myoglobinuria W78X
7 F/36 AA Cramps, myoglobinuria W78X
8 M/25 AA Cramps, myoglobinuria Tubular aggregates W78X
9 M/20 AA Cramps, myoglobinuria Tubular aggregates W78X
10 M/23 Italian Cramps, myoglobinuria R90W
11 F/31 Italian Exercise intolerance R90W
12 M/65 Italian Exercise intolerance Tubular aggregates Del532G
13 M/44 Italian Exercise intolerance R10Q/Del532G
14 M/25 Pakistani Cramps, myoglobinuria Tubular aggregates R180X
15* M/43 AA HyperCKemia Tubular aggregates W78X het
AA, African-American; het, heterozygous; NT, not tested; Pt., patient.
*Case in this report.
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